胆碱酯酶抑制剂在血管性痴呆中的治疗进展

被引：4

作者：

庞睿娟 ^{[1
]}

肖军 ^{[2
]}

机构：

[1] 泸州医学院

[2] 四川省医学科学院四川省人民医院神经内科

来源：

中华临床医师杂志(电子版) | 2012年 / 6卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R749.1 [脑器质性精神障碍];

学科分类号：

100204 [神经病学];

摘要：

<正>随着人口老龄化的发展,血管性痴呆(vascular dementia,VaD)的防治已成为研究者关注的焦点。胆碱酯酶抑制剂以往多用于阿尔茨海默病(Alzheimer's disease,AD)的治疗,但近年来其在VaD治疗中的应用越来越受到人们的重视。因为已有研究

引用

收藏

页码：2727 / 2729

页数：3

相关论文

共 13 条

[1]

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients.[J].Elisa Conti;Gloria Galimberti;Lucio Tremolizzo;Alessandro Masetto;Diletta Cereda;Clara Zanchi;Fabrizio Piazza;Marco Casati;Valeria Isella;Ildebrando Appollonio;Carlo Ferrarese.Neuroscience Letters.2010, 3

[2]

A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease [J].

Narasimhalu, K. ;

Effendy, S. ;

Sim, C. H. ;

Lee, J. M. ;

Chen, I. ;

Hia, S. B. ;

Xue, H. L. ;

Corrales, M. P. ;

Chang, H. M. ;

Wong, M. C. ;

Chen, C. P. ;

Tan, E. K. .

ACTA NEUROLOGICA SCANDINAVICA, 2010, 121 (04) :217-224

[3]

Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study [J].

Ballard, C. ;

Sauter, M. ;

Scheltens, P. ;

He, Y. ;

Barkhof, F. ;

van Straaten, E. C. W. ;

van der Flier, W. M. ;

Hsu, C. ;

Wu, S. ;

Lane, R. .

CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (09) :2561-2574

[4]

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL [J].

Dichgans, Martin ;

Markus, Hugh S. ;

Salloway, Stephen ;

Verkkoniemi, Auli ;

Moline, Margaret ;

Wang, Qin ;

Posner, Holly ;

Chabriat, Hugues S. .

LANCET NEUROLOGY, 2008, 7 (04) :310-318

[5]

Galantamine treatment of vascular dementia: A randomized trial [J].

Auchus, A. P. ;

Brashear, H. R. ;

Salloway, S. ;

Korczyn, A. D. ;

De Deyn, P. P. ;

Gassmann-Mayer, C. .

NEUROLOGY, 2007, 69 (05) :448-458

[6]

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials [J].

Kavirajan, Harish ;

Schneider, Lon S. .

LANCET NEUROLOGY, 2007, 6 (09) :782-792

[7]

Cholinergic neuronal deficits in CADASIL [J].

Keverne, Jessica S. ;

Low, Wee Chuang R. ;

Ziabreva, Iryna ;

Court, Jenny A. ;

Oakley, Arthur E. ;

Kalaria, Raj N. .

STROKE, 2007, 38 (01) :188-191

[8]

Cholinergic dysfunction in vascular dementia [J].

Román G.C. .

Current Psychiatry Reports, 2005, 7 (1) :18-26

[9]

Rivastigmine for subcortical vascular dementia.[J].Román.Expert Review of Neurotherapeutics.2005, 3

[10]

Update on rivastigmine [J].

Farlow, MR .

NEUROLOGIST, 2003, 9 (05) :230-234